|
**Overview**: **Carnitine Profile****Introduction**: The Carnitine Profile is a diagnostic tool designed to screen for carnitine deficiency using serum samples. Associated with conditions like carnitine palmitoyltransferase deficiency and systemic primary carnitine deficiency, these disorders present with muscle weakness, fatigue, and severe complications if untreated, particularly in individuals with metabolic concerns. Per the 2023 Biochemistry guidelines, the test employs biochemistry with HPLC-MS/MS technology, delivering detailed parameter analysis over 1-2 days with high sensitivity and specificity, making it a valuable tool for metabolic screening in clinical settings. This diagnostic falls under metabolic screening and targets individuals with suspected carnitine deficiency, addressing the challenge of accurate parameter assessment to guide treatment. With morbidity rates elevated due to underdiagnosis, the test supports public health efforts by enabling precise identification, facilitating management, and reducing complications. Its serum-based approach ensures reliable detection.**Other Names**: Carnitine Pfl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: Introduced in the 1990s by metabolic labs, this test advanced carnitine deficiency diagnostics.**Purpose**: The test screens for 20 parameters including free carnitine to guide metabolic assessment, assess carnitine metabolism, and inform treatment and prevention strategies.**Test Parameters**: 1. Free Carnitine, 2. Total Carnitine, 3. Acetylcarnitine, 4. Propionylcarnitine, 5. Butyrylcarnitine, 6. Isovalerylcarnitine, 7. Hexanoylcarnitine, 8. Octanoylcarnitine, 9. Decanoylcarnitine, 10. Lauroylcarnitine, 11. Myristoylcarnitine, 12. Palmitoylcarnitine, 13. Stearoylcarnitine, 14. Oleoylcarnitine, 15. Linoleoylcarnitine, 16. Hydroxybutyrylcarnitine, 17. Hydroxypalmitoylcarnitine, 18. Hydroxystearoylcarnitine, 19. Malonylcarnitine, 20. Glutarylcarnitine.**Pretest Condition**: No fasting required; patients should report muscle weakness, fatigue, or recent metabolic symptoms.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on muscle weakness, fatigue, prior metabolic reactions, or family history of metabolic disorders, as well as any recent trauma or treatments.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated carnitine deficiency including metabolic crisis, benefits of early detection, and minimal discomfort from sample collection.**Procedural Considerations**: The test involves sample processing using HPLC-MS/MS and interpret results within 1-2 days using provided controls.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, cross-contamination with other samples, or recent dietary changes can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible carnitine deficiency, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist, especially in early disease stages.**Specialist Consultation**: General practitioners or specialists in metabolic medicine should be consulted for case management, treatment planning, and coordination with health programs.**Additional Supporting Tests**: Urine organic acid analysis or genetic testing for confirmation.**Test Limitations**: The test may produce false negatives in early disease stages or false positives in dietary variation, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Biochemistry Guidelines 2023, Journal of Metabolic Disorders 2024, Chemistry 2025. |
